“It’s Time to Rebuild Domestic Drug Production in the US” from Industry Week offers compelling arguments for reshoring pharmaceutical manufacturing to (1) develop high wage jobs, the median (50th percentile) being close to $75K, and (2) reduce dependency on unreliable offshore supply chains.